Search

everythinglearnresearchcommunity

for

Search:↓

EMS and EF both show similar skin and fascia changes, but EMS has more severe symptoms and nerve inflammation.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

High doses of tryptophan may cause eosinophilic fasciitis.

A woman with EMS showed unusual skin mucinosis without the typical hard skin syndrome, suggesting EMS can cause skin mucinosis.

A woman developed a persistent skin rash and hair loss from a condition linked to her increased L-tryptophan intake.

Hair loss in a woman with eosinophilia-myalgia syndrome improved after stopping L-tryptophan and starting treatment.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

HIV can cause unusual and severe skin problems that are hard to treat.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Early treatment of acne is crucial to prevent scarring and psychological effects.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Biologics for severe asthma have known side effects, but some new risks need more study.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Minoxidil may cause heart issues in animals and humans.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Iron deficiency might contribute to hair loss in women.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The model and estimator can predict drug exposure in kidney transplant patients well.